Effects of Capsaicin on Cellular Damage and Monolayer Permeability in Human Intestinal Caco-2 Cells(Biopharmacy)
スポンサーリンク
概要
- 論文の詳細を見る
Recent studies suggest that capsaicin (Cap), a major constituent of hot pepper, may affect the function and permeability of the intestinal mucosa in vitro. However, the relationships between the dose of Cap and the barrier and/or transporter functions on intestinal epithelial cells are unknown. The aim of this study was to investigate whether Cap initiates cellular injury and alter epithelial permeability in Caco-2 cells. Cellular toxicity, as measured using a lactate dehydrogenase release assay, was not observed at high concentrations of Cap (up to 300 μM). When cell viability was measured by a WST-1 assay (tetrazolium salt-based assay), damage to Caco-2 monolayers was observed at doses of 200 and 300μM of Cap. The barrier function of tight junctions was assessed by measuring transepithelial electrical resistance (TEER) in Caco-2 cells. Treatment of Caco-2 cells with Cap at doses above 100μM significantly decreased the TEER compared to treatment with buffer alone for 2 h (p<0.05). We next examined the effects of Cap on the activity of P-glycoprotein (P-gp) found on transcellular transporters. At doses of 100 and 200μM, Cap inhibited the transport of rhodamine 123 by P-gp-mediated efflux in Caco-2 cells. Cap thus exhibited inhibitory effects on P-gp. The results of this study indicate that Cap, a dietary phytochemical, causes functional and structural changes in Caco-2 cell monolayers at noncytotoxic doses (less than 100μM of Cap). The concomitant administration of Cap with drugs that are substrates of P-gp might increase the plasma concentrations of such drugs.
- 社団法人日本薬学会の論文
- 2007-10-01
著者
-
Kato Ryuji
Department Of Clinical Pharmacology & Pharmacokinetics Osaka University Of Pharmaceutical Scienc
-
KATO Ryuji
Laboratory of Clinical Pharmacy and Clinical Pharmacokinetics, Osaka University of Pharmaceutical Sc
-
TSUKURA Yuri
Laboratory of Clinical Pharmacy and Clinical Pharmacokinetics, Osaka University of Pharmaceutical Sc
-
AMANO Fumio
Laboratory of Biodefense and Regulation, Osaka University of Pharmaceutical Sciences
-
HIROTANI Yoshihiko
Laboratory of Clinical Pharmaceutics, Faculty of Pharmacy, Osaka Ohtani University
-
IJIRI Yoshio
Laboratory of Clinical Pharmacy and Clinical Pharmacokinetics, Osaka University of Pharmaceutical Sc
-
TANAKA Kazuhiko
Laboratory of Clinical Pharmacy and Clinical Pharmacokinetics, Osaka University of Pharmaceutical Sc
-
Tsukura Yuri
大阪薬科大学 臨床薬剤学研究室
-
Tsukura Yuri
Laboratory Of Clinical Pharmacy And Clinical Pharmacokinetics Osaka University Of Pharmaceutical Sci
-
Tsukura Yuri
Department Of Clinical Pharmacy And Clinical Pharmacokinetics Osaka University Of Pharmaceutical Sci
-
Kato Ryuji
新潟薬科大学 薬学部
-
Tokunaga Yuka
大阪薬科大学 臨床薬剤学研究室
-
Ijiri Yoshio
大阪薬科大学 臨床薬剤学研究室
-
Ijiri Yoshio
Laboratory Of Clinical Pharmacy And Clinical Pharmacokinetics Osaka University Of Pharmaceutical Sci
-
Amano Fumio
大阪薬科大学 臨床薬剤学研究室
-
Amano Fumio
Laboratory Of Biodefense And Regulation Osaka University Of Pharmaceutical Sciences
-
Amano Fumio
Laboratory Of Biodefense & Regulation Osaka University Of Pharmaceutical Sciences
-
Hirotani Yoshihiko
Laboratory Of Clinical Pharmaceutics Faculty Of Pharmacy Osaka Ohtani University
-
Hirotani Yoshihiko
大阪薬科大学 臨床薬剤学研究室
-
MORI Maya
Laboratory of Clinical Pharmacy & Clinical Pharmacokinetics, Osaka University of Pharmaceutical Scie
-
IKEDA Kenji
Laboratory of Clinical Pharmaceutics, Faculty of Pharmacy, Osaka Ohatani University
-
Mori Maya
Laboratory Of Clinical Pharmacy & Clinical Pharmacokinetics Osaka University Of Pharmaceutical S
-
Ijiri Yoshio
Department Of Clinical Pharmacy And Clinical Pharmacokinetics Osaka University Of Pharmaceutical Sci
-
Tanaka Kazuhiko
Department Of Clinical Pharmacology & Pharmacokinetics Osaka University Of Pharmaceutical Scienc
-
Hirotani Yoshihiko
大阪大谷大学 薬学部臨床薬剤学
-
Ikeda Kenji
Laboratory Of Clinical Pharmaceutics Faculty Of Pharmacy Osaka Ohtani University
関連論文
- The Effect of Bucolome, a CYP2C9 Inhibitor, on the Pharmacokinetics of Losartan
- Effect of Amiodarone on the Serum Concentration/Dose Ratio of Metoprolol in Patients with Cardiac Arrhythmia
- Prediction of Cibenzoline Dose from that of Digoxin
- Effects of CpG-DNA from Escherichia coli on Digoxin Pharmacokinetics(Biopharmacy)
- Changes in Digoxin Pharmacokinetics Treated with Lipopolysaccharide in Wistar Rats(Biopharmacy)
- Effects of Capsaicin on Cellular Damage and Monolayer Permeability in Human Intestinal Caco-2 Cells(Biopharmacy)
- Effects of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on Hyperglycemia in Streptozotocin-Induced Diabetic Rats(Biopharmacy)
- Correlation between Plasma Glucagon-Like Peptide 2 Levels and Proliferative Makers in Small Intestinal Injury in Rats Induced by Methotrexate Administration(Biopharmacy)
- Protective Effects of Capsaicin against Cisplatin-Induced Nephrotoxicity in Rats(Pharmacology)
- Synthesis of Rat Glucagon-Like Peptide (GLP)-2 and Its Biological and Immunochemical Studies
- Capsaicin Improves Survival Rate in Mice with Lipopolysaccharide-Induced Endotoxin Shock
- Marked Effect of Steroid-Resistant Focal Sclerotic Nephrotic Syndrome by Concomitant Therapy with LDL-Apheresis and Cyclosporine
- Dry-Resistance of Salmonella enterica subsp. enterica Serovar Enteritidis is Regulated by Both SEp22, a Novel Pathogenicity-Related Factor of Salmonella, and Nutrients
- An Anti-Salmonella Antibody Prevents the Salmonella enterica serovar Enteritidis from Infecting the Human Intestinal Epithelial Cell Line, Caco-2, by Interacting with Flagella
- Differential stereoselective effects of levobupivacaine, bupivacaine and dexbupivacaine on the heart in isolated rat hearts
- Lactoferrin Inhibits the Acquisition of Dry-Resistance of Salmonella spp.
- Endotoxin-Tolerance to the Cytotoxicity toward a Macrophage-Like Cell Line, J774.1, Induced by Lipopolysaccharide and Cycloheximide: Role of p38 MAPK in Induction of the Cytotoxicity(Highlighted paper selected by Editor-in-chief)(Biochemistry/Molecular Bi
- Regulation of SEp22 Expression in Salmonella enterica subsp. enterica Serovar Enteritidis by Culture Medium
- Diverse Pathogenicity of Salmonella Enteritidis Clones Isolated from Poultry Farms in Chicks and BALB/c Mice
- Structural Studies on Strained-Layer Lattices
- Dialyzability of the Antiepileptic Drug Zonisamide in Patients Undergoing Hemodialysis
- Regulatory role of cardiolipin in the activity of an ATP-dependent protease, Lon, from Escherichia coli
- Role of cytokines in lavage or drainage fluid after hemithyroidectomy in wound healing : Involvement of histamine in the acceleration and delay of wound healing